| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PAHC over the last quarter tilts toward buying: insiders added a net 10,000 shares worth roughly $318K.
PAHC sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 51.5K | $1.87M | - | |
| Dir | 41.5K | $1.51M | - | |
| COO | 34.5K | $1.25M | - | |
| Other | 14.5K | $528.0K | - | |
| CEO | 3.5K | $126.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2018 | Bfi Co., LLC | 10% Owner | Sell | 520 | $45.04 | $23,420.80 | -0.9% | |
| Sep 6, 2018 | Bfi Co., LLC | 10% Owner | Sell | 20,000 | $47.14 | $942,718.00 | -16.6% | |
| Sep 6, 2018 | Bendheim Jack55 | President And CEO | Sell | 20,000 | $47.14 | $942,718.00 | -16.6% | |
| Aug 23, 2018 | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $50.04 | $1,501,100.00 | -20.0% | |
| Aug 23, 2018 | Bendheim Jack55 | President And CEO | Sell | 30,000 | $50.04 | $1,501,100.00 | -20.0% | |
| Aug 15, 2018 | Bendheim Jack55 | President And CEO | Sell | 30,000 | $49.75 | $1,492,600.00 | -20.0% | |
| Aug 15, 2018 | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $49.75 | $1,492,600.00 | -20.0% | |
| Aug 8, 2018 | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $50.20 | $1,505,955.00 | -51.3% | |
| Aug 8, 2018 | Bendheim Jack55 | President And CEO | Sell | 30,000 | $50.20 | $1,505,955.00 | -51.3% | |
| Jul 27, 2018 | Bendheim Jack55 | President And CEO | Sell | 12,000 | $47.35 | $568,200.00 | -15.4% |